Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
    • General
    • Datos de investigación
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
  • Contacto
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Artículo

Resistance against the development of diethylnitrosamine-induced hepatocellular carcinoma in female C3H mice: an experimental model

Montagna, Daniela RominaIcon ; Todero, Maria FlorenciaIcon ; Postma, Gabriela; Trigo, Roberto Héctor; Bernal, Alan MauroIcon ; Bustuoabad, Oscar DavidIcon ; Vermeulen, Elba MonicaIcon ; Ruggiero, Raul AlejandroIcon ; Duarte, Alejandra BeatrizIcon
Fecha de publicación: 10/2024
Editorial: Int Press Editing Centre Inc
Revista: Experimental Animals
ISSN: 1341-1357
e-ISSN: 1881-7122
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:
Otras Ciencias Biológicas

Resumen

Histopathological features of hepatocellular carcinoma (HCC) induced by diethylnitrosamine (DEN) in mice display strong similarities with those seen in humans, including the higher tumor prevalence in males than in females. Previous studies have demonstrated that continual production of the pro-inflammatory IL-6 by Kupffer cells is involved in the initiation and progression of DEN-induced HCC and that estrogen-mediated reduction of IL-6 secretion would decrease its incidence in females. Given the predominant utilization of male mice in hepatic carcinogenesis research, the objective of this study was to examine histopathological and immunological parameters in the DEN-induced liver carcinogenesis model in female C3H mice. We observed a significant prevalence of hepatocellular hyperplasias and adenomas alongside a minimal infiltration of inflammatory cells and a scarcity of senescent areas in females. Further, a low expression of immunosuppression markers is observed in females − such as neutrophil/lymphocyte ratio, PD-1 expression in CD8 T cells, and PD-L1 in myeloid cells − compared to males. Comparative studies between susceptible and resistant hosts to chemical carcinogenesis may help to unveil novel therapeutic strategies against cancer.
Palabras clave: ENVEJECIMIENTO Y CÁNCER , TUMORES MURINOS DE HÍGADO , DIFERENCIAS DE GÉNERO , DIETILNITROSAMINA
Ver el registro completo
 
Archivos asociados
Thumbnail
 
Tamaño: 3.111Mb
Formato: PDF
.
Descargar
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Atribución-NoComercial-SinDerivadas 2.5 Argentina (CC BY-NC-ND 2.5 AR)
Identificadores
URI: http://hdl.handle.net/11336/266377
URL: https://www.jstage.jst.go.jp/article/expanim/73/4/73_23-0149/_article
DOI: http://dx.doi.org/10.1538/expanim.23-0149
Colecciones
Articulos(IMEX)
Articulos de INST.DE MEDICINA EXPERIMENTAL
Articulos(INIGEM)
Articulos de INSTITUTO DE INMUNOLOGIA, GENETICA Y METABOLISMO
Citación
Montagna, Daniela Romina; Todero, Maria Florencia; Postma, Gabriela; Trigo, Roberto Héctor; Bernal, Alan Mauro; et al.; Resistance against the development of diethylnitrosamine-induced hepatocellular carcinoma in female C3H mice: an experimental model; Int Press Editing Centre Inc; Experimental Animals; 73; 4; 10-2024; 399-411
Compartir
Altmétricas
 

Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • X Conicet Digital
  • Instagram
  • YouTube
  • Sound Cloud
  • LinkedIn

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal

Contacto

Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES